Norges Bank Supernus Pharmaceuticals, Inc. Transaction History

Norges Bank

$736 Billion
Q4 2024

A detailed history of Norges Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Norges Bank holds 125,551 shares of SUPN stock, worth $4.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,551

Holding current value

$4.96 Million

% of portfolio

0.0%

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$31.89 - $37.83 $4 Million - $4.75 Million	125,551 New	125,551 $4.54 Million
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $5.43 Million - $7.07 Million	208,835 New	208,835 $5.59 Million
Q4 2023 Feb 09, 2024	BUY	$22.72 - $29.68 $6.25 Million - $8.17 Million	275,140 New	275,140 $7.96 Million
Q3 2023 Nov 13, 2024	BUY	$27.57 - $32.91 $8.2 Million - $9.78 Million	297,288 New	297,288 $8.2 Million
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $11.8 Million - $14.1 Million	-428,573 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$29.91 - $38.73 $3.94 Million - $5.11 Million	131,812 Added 63.12%	340,647 $10.2 Million
Q2 2023 Aug 14, 2023	SELL	$29.91 - $38.73 $12.8 Million - $16.6 Million	-428,573 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$34.93 - $42.03 $12.5 Million - $15 Million	357,100 New	357,100 $12.9 Million
Q4 2022 Feb 14, 2023	BUY	$31.09 - $37.88 $13.3 Million - $16.2 Million	428,573 New	428,573 $15.3 Million
Q3 2022 Nov 13, 2023	BUY	$28.79 - $35.41 $12.3 Million - $15.2 Million	428,573 New	428,573 $14.5 Million
Q2 2022 Aug 14, 2023	BUY	$25.33 - $34.25 $10.9 Million - $14.7 Million	428,573 New	428,573 $12.4 Million
Q1 2022 May 12, 2023	BUY	$28.51 - $32.9 $1.33 Million - $1.53 Million	46,561 Added 10.86%	475,134 $15.4 Million
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $14.1 Million - $16.3 Million	-495,313 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$26.37 - $34.22 $13.1 Million - $16.9 Million	495,313 New	495,313 $14.4 Million
Q3 2021 Nov 14, 2022	BUY	$23.54 - $31.39 $10.4 Million - $13.8 Million	440,650 New	440,650 $11.8 Million
Q3 2021 Nov 05, 2021	SELL	$23.54 - $31.39 $9.74 Million - $13 Million	-413,763 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$26.72 - $33.19 $11.1 Million - $13.7 Million	413,763 New	413,763 $12.7 Million
Q2 2021 Aug 10, 2021	SELL	$26.72 - $33.19 $13 Million - $16.1 Million	-485,679 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$24.15 - $31.45 $11.7 Million - $15.3 Million	485,679 New	485,679 $12.7 Million
Q1 2021 May 07, 2021	SELL	$24.15 - $31.45 $12.8 Million - $16.7 Million	-530,928 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$17.7 - $25.81 $9.4 Million - $13.7 Million	530,928 New	530,928 $13.4 Million
Q4 2020 Feb 10, 2021	SELL	$17.7 - $25.81 $10.3 Million - $15 Million	-581,894 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$20.2 - $25.05 $11.8 Million - $14.6 Million	581,894 New	581,894 $12.1 Million
Q3 2020 Nov 10, 2020	SELL	$20.2 - $25.05 $12.8 Million - $15.9 Million	-635,120 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$17.09 - $24.89 $10.9 Million - $15.8 Million	635,120 New	635,120 $15.1 Million
Q2 2020 Aug 07, 2020	SELL	$17.09 - $24.89 $11.9 Million - $17.4 Million	-698,547 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$14.45 - $24.69 $10.1 Million - $17.2 Million	698,547 New	698,547 $12.6 Million
Q1 2020 May 08, 2020	SELL	$14.45 - $24.69 $10.1 Million - $17.2 Million	-698,547 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$19.93 - $29.13 $13.9 Million - $20.3 Million	698,547 New	698,547 $16.6 Million
Q4 2019 Feb 12, 2020	SELL	$19.93 - $29.13 $13.9 Million - $20.3 Million	-698,547 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$25.47 - $33.37 $17.8 Million - $23.3 Million	698,547 New	698,547 $19.2 Million
Q3 2019 Nov 08, 2019	SELL	$25.47 - $33.37 $18.6 Million - $24.4 Million	-729,845 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$29.96 - $38.87 $21.9 Million - $28.4 Million	729,845 New	729,845 $24.2 Million
Q2 2019 Aug 09, 2019	SELL	$29.96 - $38.87 $21.9 Million - $28.4 Million	-729,845 Closed	0 $0
Q1 2019 May 11, 2020	SELL	$32.77 - $41.99 $458,780 - $587,860	-14,000 Reduced 1.88%	729,845 $25.6 Million
Q4 2018 Mar 04, 2019	BUY	$30.84 - $49.51 $22.9 Million - $36.8 Million	743,845 New	743,845 $24.7 Million
Q4 2018 Feb 08, 2019	SELL	$30.84 - $49.51 $22.9 Million - $36.8 Million	-743,845 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$42.7 - $56.55 $31.8 Million - $42.1 Million	743,845 New	743,845 $37.5 Million
Q3 2018 Nov 09, 2018	SELL	$42.7 - $56.55 $31.8 Million - $42.1 Million	-743,845 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$44.1 - $59.85 $32.8 Million - $44.5 Million	743,845 New	743,845 $44.5 Million
Q2 2018 Jul 23, 2018	SELL	$44.1 - $59.85 $29.2 Million - $39.6 Million	-662,409 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$37.15 - $46.9 $24.6 Million - $31.1 Million	662,409 New	662,409 $30.3 Million
Q1 2018 May 09, 2018	SELL	$37.15 - $46.9 $21.8 Million - $27.5 Million	-586,591 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$36.4 - $42.6 $21.4 Million - $25 Million	586,591 New	586,591 $23.4 Million
Q4 2017 Feb 09, 2018	SELL	$36.4 - $42.6 $14.6 Million - $17.1 Million	-401,193 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$36.75 - $49.65 $14.7 Million - $19.9 Million	401,193	401,193 $16 Million

Others Institutions Holding SUPN

# of Institutions

299

Shares Held

60.9M

Call Options Held

27.7K

Put Options Held

11.3K

Black Rock Inc. New York, NY

10.4M
Shares

$411 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.15M
Shares

$243 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.1M
Shares

$201 Million
2.64% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.88M
Shares

$114 Million
0.03% of portfolio
Macquarie Group LTD Australia, C3

2.63M
Shares

$104 Million
0.11% of portfolio

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account